
APEX Biologix has expanded its XCELL Bone Marrow Concentration (BMC) Products to include a second bone marrow system specifically designed for ambulatory surgery centers (ASCs) and hospital operating rooms. This bone marrow concentration kit enhances the APEX Biologix XCELL products that target the orthobiologic space.
APEX’s XCELL BMC is designed to maximize mesenchymal stem cell (MSC) count in a cost-affordable and easy-to-use system. The system shortens total processing time and has a customized benchtop processing device that reduces human error through steps intended to maximize total nucleated cell concentration numbers.
The extended XCELL BMC kits provide an easy-to-use and adaptable system that provides surgeons up to 8cc of MSCs per 60mL draw, which the company describes as a best-in-class concentration level.
Source: APEX Biologix
APEX Biologix has expanded its XCELL Bone Marrow Concentration (BMC) Products to include a second bone marrow system specifically designed for ambulatory surgery centers (ASCs) and hospital operating rooms. This bone marrow concentration kit enhances the APEX Biologix XCELL products that target the orthobiologic space.
APEX’s XCELL BMC is...
APEX Biologix has expanded its XCELL Bone Marrow Concentration (BMC) Products to include a second bone marrow system specifically designed for ambulatory surgery centers (ASCs) and hospital operating rooms. This bone marrow concentration kit enhances the APEX Biologix XCELL products that target the orthobiologic space.
APEX’s XCELL BMC is designed to maximize mesenchymal stem cell (MSC) count in a cost-affordable and easy-to-use system. The system shortens total processing time and has a customized benchtop processing device that reduces human error through steps intended to maximize total nucleated cell concentration numbers.
The extended XCELL BMC kits provide an easy-to-use and adaptable system that provides surgeons up to 8cc of MSCs per 60mL draw, which the company describes as a best-in-class concentration level.
Source: APEX Biologix
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





